Medpace Holdings, Inc. Long-term Purchase Commitment, Amount
Medpace Holdings, Inc. (MEDP) reported Long-term Purchase Commitment, Amount of $29.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LongTermPurchaseCommitmentAmount · last filed 2026-07-23
- Medpace Holdings, Inc. long-term purchase commitment, amount for the quarter ending 2026-06-30 was $10.70M, a 5250.00% increase year-over-year.
- Medpace Holdings, Inc. long-term purchase commitment, amount for the quarter ending 2026-03-31 was $18.70M, a 5.06% increase year-over-year.
- Medpace Holdings, Inc. long-term purchase commitment, amount for the quarter ending 2025-12-31 was $800.00K.
- Medpace Holdings, Inc. long-term purchase commitment, amount for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Medpace Holdings, Inc. long-term purchase commitment, amount for fiscal 2025 was $18.80M, a 20.51% increase from fiscal 2024.
- Medpace Holdings, Inc. long-term purchase commitment, amount for fiscal 2024 was $15.60M, a 9.30% decline from fiscal 2023.
- Medpace Holdings, Inc. long-term purchase commitment, amount for fiscal 2023 was $17.20M, a 1.18% increase from fiscal 2022.
- Medpace Holdings, Inc. long-term purchase commitment, amount for fiscal 2022 was $17.00M, a 40.50% increase from fiscal 2021.
| Period end | Long-term Purchase Commitment, Amount 1 month | Long-term Purchase Commitment, Amount 3 month | Long-term Purchase Commitment, Amount 6 month | Long-term Purchase Commitment, Amount 9 month | Long-term Purchase Commitment, Amount 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $10.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $29.40M 10-Q · filed 2026-07-23 | $30.20M derived: sum of 3 quarters · filed 2026-07-23 | $30.20M derived: sum of 4 quarters · filed 2026-07-23 | |
| 2026-03-31 | $18.70M 10-Q · filed 2026-04-23 | $19.50M derived: sum of 2 quarters · filed 2026-04-23 | $19.50M derived: sum of 3 quarters · filed 2026-04-23 | $19.70M derived: sum of 4 quarters · filed 2026-04-23 | |
| 2025-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $800.00K derived: sum of 2 quarters · filed 2026-02-10 | $1.00M derived: sum of 3 quarters · filed 2026-02-10 | $18.80M 10-K · filed 2026-02-10 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $200.00K derived: sum of 2 quarters · filed 2025-10-23 | $18.00M 10-Q · filed 2025-10-23 | $17.70M derived: sum of 4 quarters · filed 2025-10-23 | |
| 2025-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | $18.00M 10-Q · filed 2025-07-22 | $17.70M derived: sum of 3 quarters · filed 2025-07-22 | $18.70M derived: sum of 4 quarters · filed 2025-07-22 | |
| 2025-03-31 | $17.80M 10-Q · filed 2025-04-22 | $17.50M derived: sum of 2 quarters · filed 2025-04-22 | $18.50M derived: sum of 3 quarters · filed 2025-04-22 | $18.50M derived: sum of 4 quarters · filed 2025-04-22 | |
| 2024-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $700.00K derived: sum of 2 quarters · filed 2025-02-11 | $700.00K derived: sum of 3 quarters · filed 2025-02-11 | $15.60M 10-K · filed 2025-02-11 | |
| 2024-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-22 | $1.00M derived: sum of 2 quarters · filed 2024-10-22 | $15.90M 10-Q · filed 2024-10-22 | $16.20M derived: sum of 4 quarters · filed 2024-10-22 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-23 | $14.90M 10-Q · filed 2024-07-23 | $15.20M derived: sum of 3 quarters · filed 2024-07-23 | $15.00M derived: sum of 4 quarters · filed 2024-07-23 | |
| 2024-03-31 | $14.90M 10-Q · filed 2024-04-23 | $15.20M derived: sum of 2 quarters · filed 2024-04-23 | $15.00M derived: sum of 3 quarters · filed 2024-04-23 | $15.00M derived: sum of 4 quarters · filed 2024-04-23 | |
| 2023-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $100.00K derived: sum of 2 quarters · filed 2024-02-13 | $100.00K derived: sum of 3 quarters · filed 2024-02-13 | $17.20M 10-K · filed 2024-02-13 | |
| 2023-09-30 | -$200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-24 | -$200.00K derived: sum of 2 quarters · filed 2023-10-24 | $16.90M 10-Q · filed 2023-10-24 | $19.60M derived: sum of 4 quarters · filed 2023-10-24 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | $17.10M 10-Q · filed 2023-07-25 | $19.80M derived: sum of 3 quarters · filed 2023-07-25 | $19.40M derived: sum of 4 quarters · filed 2023-07-25 | |
| 2023-03-31 | $17.10M 10-Q · filed 2023-04-25 | $19.80M derived: sum of 2 quarters · filed 2023-04-25 | $19.40M derived: sum of 3 quarters · filed 2023-04-25 | $22.20M derived: sum of 4 quarters · filed 2023-04-25 | |
| 2022-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $2.30M derived: sum of 2 quarters · filed 2023-02-14 | $5.10M derived: sum of 3 quarters · filed 2023-02-14 | $17.00M 10-K · filed 2023-02-14 | |
| 2022-09-30 | -$400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | $2.40M derived: sum of 2 quarters · filed 2022-10-25 | $14.30M 10-Q · filed 2022-10-25 | $14.20M derived: sum of 4 quarters · filed 2022-10-25 | |
| 2022-06-30 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-26 | $14.70M 10-Q · filed 2022-07-26 | $14.60M derived: sum of 3 quarters · filed 2022-07-26 | $14.50M derived: sum of 4 quarters · filed 2022-07-26 | |
| 2022-03-31 | $11.90M 10-Q · filed 2022-04-26 | $11.80M derived: sum of 2 quarters · filed 2022-04-26 | $11.70M derived: sum of 3 quarters · filed 2022-04-26 | $11.40M derived: sum of 4 quarters · filed 2022-04-26 | |
| 2021-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | -$200.00K derived: sum of 2 quarters · filed 2022-02-15 | -$500.00K derived: sum of 3 quarters · filed 2022-02-15 | $12.10M 10-K · filed 2022-02-15 | |
| 2021-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-26 | -$400.00K derived: sum of 2 quarters · filed 2021-10-26 | $12.20M 10-Q · filed 2021-10-26 | $14.50M derived: sum of 4 quarters · filed 2021-10-26 | |
| 2021-06-30 | -$300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | $12.30M 10-Q · filed 2021-07-27 | $14.60M derived: sum of 3 quarters · filed 2021-07-27 | $12.90M derived: sum of 4 quarters · filed 2021-07-27 | |
| 2021-03-31 | $12.60M 10-Q · filed 2021-04-27 | $14.90M derived: sum of 2 quarters · filed 2021-04-27 | $13.20M derived: sum of 3 quarters · filed 2021-04-27 | $13.30M derived: sum of 4 quarters · filed 2021-04-27 | |
| 2020-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $600.00K derived: sum of 2 quarters · filed 2021-02-16 | $700.00K derived: sum of 3 quarters · filed 2021-02-16 | $12.50M 10-K · filed 2021-02-16 | |
| 2020-09-30 | -$1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | -$1.60M derived: sum of 2 quarters · filed 2020-10-27 | $10.20M 10-Q · filed 2020-10-27 | $11.00M derived: sum of 4 quarters · filed 2020-10-27 | |
| 2020-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | $11.90M 10-Q · filed 2020-07-28 | $12.70M derived: sum of 3 quarters · filed 2020-07-28 | $13.40M derived: sum of 4 quarters · filed 2020-07-28 | |
| 2020-03-31 | $11.80M 10-Q · filed 2020-04-29 | $12.60M derived: sum of 2 quarters · filed 2020-04-29 | $13.30M derived: sum of 3 quarters · filed 2020-04-29 | $13.60M derived: sum of 4 quarters · filed 2020-04-29 | |
| 2019-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $1.50M derived: sum of 2 quarters · filed 2020-02-25 | $1.80M derived: sum of 3 quarters · filed 2020-02-25 | $11.90M 10-K · filed 2020-02-25 | |
| 2019-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $1.00M derived: sum of 2 quarters · filed 2019-10-29 | $11.10M 10-Q · filed 2019-10-29 | ||
| 2019-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $10.40M 10-Q · filed 2019-07-30 | |||
| 2019-03-31 | $10.10M 10-Q · filed 2019-04-30 | ||||
| 2018-12-31 | $5.20M 10-K · filed 2019-02-26 | ||||
| 2016-12-31 | $0.00 10-K · filed 2017-02-28 | ||||
| 2013-05-31 | $2.00M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |